University of Zurich
Date of Award
08.24.2021
Program
Type 1 Diabetes, Prevent & Delay
Amount
$245,080
Term of Grant
24 months
Project Title
Generation of a bispecific interleukin-2 immunotherapy for preferential and pancreas-targeted stimulation of regulatory T cells in the treatment of type-1 diabetes mellitus
Project Description
Funds support activities into designing and preclinically testing a targeted immunotherapy for type 1 diabetes (T1D).